Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

MDH Radiology taps Sectra for nationwide telemammography service

MDH Radiology has signed an agreement with Sectra to utilize Sectra Breast Imaging PACS for the remote reading of mammograms.

Slim chance: Morbidity poses larger mortality risk than CT for young adults

The risk of death from underlying medical morbidity far outweighs the risk of death from radiation-induced cancer among young adults undergoing body CT imaging. The study was published February 5 in Radiology.

Siemens, ASRT Foundation to renew scholarship partnership

The American Society of Radiologic Technologists (ASRT) Foundation and Siemens will renew the Siemens Clinical Advancement Scholarship through 2018.

ViewRay appoints new president and CEO

ViewRay’s board of directors has appointed Chris A. Raanes as president and CEO, effective immediately.

One-fourth of very low risk kids undergo abdominal CT

A total of 25 percent of children presenting to the emergency department at very low risk for intra-abdominal injuries underwent abdominal CT, results of a study published in the February issue of Annals of Emergency Medicine showed.  A clinical prediction rule that identifies children with blunt torso trauma at very low risk for intra-abdominal injury may obviate CT scanning for some patients.

Whole-body MRI falls short in detecting distant metastases in kids

Whole-body MRI is not justified as the initial study for staging of pediatric malignant tumors, with accuracy no better than conventional imaging for detection of distant metastatic disease, according to a study published in the February issue of Radiology.

CMS panel finds lack of evidence to support beta-amyloid PET

Panelists voted “low to intermediate confidence” during a Jan. 30 hearing in response to whether there is adequate evidence available to determine whether or not PET imaging of beta-amyloid changes health outcomes in patients with early symptoms or signs of cognitive dysfunction.

Biomarkers & lung nodule follow-up: Refiguring the math

The National Lung Screening Trial (NLST) delivered some very positive statistics, capped by the 20 percent relative mortality risk reduction among high-risk individuals undergoing three rounds of CT screening. However, other statistics, particularly those associated with follow-up nodules, may be a bit more problematic. Various research teams are focusing on the development and validation of biomarkers, including imaging biomarkers, to address some of these challenges.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.